For research use only. We do not sell to patients.
LCL161
CAS No. : 1005342-46-0
Biological Activity：LCL161 is a IAP inhibitor which inhibits XIAP in HEK293 cell and cIAP1 in MDA-MB-231 cell with IC50s of 35 and 0.4 nM, respectively.
Research Area：Cancer
Targets：IAP
Related Screening Libraries:Drug Repurposing Compound Library Plus;Clinical Compound Library Plus;Bioactive Compound Library Plus;Apoptosis Compound Library;Anti-Cancer Compound Library;Clinical Compound Library;Drug Repurposing Compound Library;Anti-Pancreatic Cancer Compound Library;Anti-Prostate Cancer Compound Library;
Related Small Molecules:Xevinapant;XIAP degrader-1;MX69;APG-1387;SBP-0636457;GDC-0152;Birinapant;TD1092;SM-164;CUDC-427;BV6;SM-1295;AZD5582;MV1;XIAP/cIAP1 antagonist-1;FL118;Polygalacin D;SM-433 hydrochloride;LBW242;UC-112;ASTX660;SM-433;Embelin
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
